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Introduction
Anthocyanins are a group of water-soluble plant pigments responsible for the deep rich purple/red/blue colours observed in plant-based foods. They are one of the major subclasses of flavonoids, a class of polyphenols. Their role in human health has been established in epidemiological studies, including improved vision (1) , cognition and blood pressure (2, 3) , and protective effects against cardiovascular disease risk factors (4) . The metabolism of anthocyanins has been well reviewed (5) . Briefly, anthocyanins consumed through the diet have been shown to be poorly absorbed by the body, with only a small proportion of intact anthocyanins being able to pass through the gastrointestinal wall using active transporters such as the sodium-dependent glucose transporter 1 and facilitative glucose transporter 2 (6) . The anthocyanins absorbed in the gastrointestinal tract are not only mainly found in methylated, sulphated or glucuronidated forms, but also as intact glycosides in very low concentrations in biological fluids such as blood (plasma) and urine (10-2000 nM) (5) . Even though the bioavailability of intact anthocyanins in the body is reportedly low, a considerable amount of (food) matrixbound anthocyanins can reach the large intestine and the colon. Here, they undergo further intensive metabolism and degradation and are absorbed into the bloodstream, with some of the subsequent metabolites showing potential to be more biologically active than the intact anthocyanins (5, 7) . The recent interest in the gut microbiota and its role in human health has implications for furthering the understanding of the effect of anthocyanins on gut microbiota and subsequent health benefits (8) . The gut microbiota, which comprises the microbe population living in the intestine, contains tens of trillions of microorganisms and is made up of at least 1000 different species of identified bacteria (9) . The majority of the bacteria in the gut are categorised under seven phyla, namely Firmicutes, Bacteroidetes, Proteobacteria, Fusobacteria, Verrucomicrobia, Cyanobacteria and Actinobacteria, with the Firmicutes and Bacteroidetes phyla making up over 90% of the human gut microbiota (10, 11) . Some of the essential functions of the gut microbiota include vitamin production, regulation of lipid metabolism, short-chain fatty acid production as fuel for epithelial cells and regulation of gene expression (12) , as well as an important functional role in the gut-brain axis relationship (13) . A healthy gut, which comprises effective digestion and absorption of food, absence of gastrointestinal illness, normal and stable intestinal microbiota, and effective immune status, is required to sustain host homeostasis (14) . Irregularities and imbalances in the microbiota at different ages have been linked to different diseases and metabolic conditions across the lifespan, ranging from allergies in young infants to inflammatory bowel disease in young adults (15) . Research on the gut microbiota continues to shed light on the health effects of changes to the gut microbiota modulated by diet. Different techniques have been described for the determination of gut microbiota. Advancement in the taxonomical composition of the gut microbiota was limited until the 21st Century as a result of bacteriological culture being the only method available to determine its composition. Even to date, only approximately 30% of the gut microbiota has been cultured (10) . Further understanding of the human gut has been improved by advanced techniques independent of bacteriological culture. Prior to these advancements, culture and biochemical typing were the gold standards for the identification of bacteria species, although they have now been overtaken by methods that are able to produce a much representative information of the overall microbiota (16) .
Examples of some of these techniques are sequencing of the 16S rRNA gene or its amplicons, fluorescence in situ hybridisation (FISH), quantitative polymerase chain reaction (qPCR), denaturing gradient gel electrophoresis and terminal restriction fragment length polymorphism. With these methods, researchers are able to obtain qualitative and quantitative information on the diversity of the gut microbiota, as well as changes in the gut microbiota in relation to an intervention or disease (17) . Improved scientific methods of gut microbiota determination have also presented the issue of the suitability of the different techniques used and how the results compare to each another.
Alterations of the gut microbiota have been shown to induce and promote or reduce the risk of chronic diseases. This hypothetical mechanism has been applied to the field of obesity and obesity-related nonalcoholic fatty liver disease in relation to prebiotics/probiotics (18, 19) and anthocyanins (20) as gut modifiers. With this question in mind, and given this rapidly advancing area of research in gut health, a systematic literature review has been undertaken to summarise the current evidence on the effect of anthocyanins on the gut microbiota. The included studies were also assessed for the different techniques used in microbiota determination. It is hypothesised that supplementation of the diet with anthocyanin-rich foods promotes the proliferation of healthy anaerobic bacterial populations, at the same time as inhibiting the pathogenic species evidenced in different gut microbiota determination techniques.
Materials and methods
A systematic literature review was conducted according to recommendations of the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement and checklist (21) (Fig. 1 ; see also Supporting information, Table S1 ). Scientific databases, including Scopus, PubMed, ScienceDirect, Web of Science and MEDLINE, were searched up to June 2017. A combination of search terms with truncations included the following keywords: anthocyanins and gut microbiota or colon microbiota ( Table 1 ). The review was registered on PROSPERO (International prospective register of systematic reviews) as CRD42017073750 (22) . Eligibility criteriaStudies were included if (Table 2 ):
• They were carried out either in vitro, on animals or in human subjects;
• They quantified the effect of anthocyanin on gut microbial population and described the method used;
• They utilised anthocyanin extracts or anthocyaninrich foods with anthocyanin (individual compounds or total) content being measured and stated;
• They assessed changes in gut microbiota associated with anthocyanin metabolism in the gut;
• They reported in the English language for reasons of time efficiency and because the cost of translation was not feasible for the present review.
Exclusion criteria
Studies were excluded if:
• They measured the stability of anthocyanins in the gut without quantifying effects on gut microbial population;
• There was no measure of anthocyanin content in food/beverage source [one study (23) met these criteria but was included because anthocyanin content was measured indirectly through the use of anthocyanin metabolites in the urine and was the only included clinical trial];
• They measured total polyphenols or flavonoids in general and not specifically the subclass of anthocyanins.
Review articles were excluded from the search but were considered for hand searching. Hand searching of reference lists was undertaken for all included studies and review articles. All selected abstracts and citations were exported from the scientific databases to the reference management software ENDNOTE X7 (Thompson Reuters, New York, NY, USA). Following extraction and selection of publications according to the above eligibility criteria, a tabular summary was developed for the present review, which included the population, design, intervention, anthocyanin dosage, health outcomes and results.
Results
The database searches returned 542 articles, and one additional study was identified via hand searching of reference lists. Following removal of duplicates and screening of records, 28 full-text articles were evaluated and only six studies were eligible and therefore included in the present review ( Fig. 1) . The included studies are summarised in Table 3 and are briefly described below.
In vitro studies
Three in vitro studies were included in this review. Anthocyanins were tested individually or in a mixture; for example, as in the case of enocianin, a commercial food colouring from Vitis vinifera grape peel that contains a mixture of anthocyanins, including malvidin-3-glucoside (200 and 20 mg L -1 , respectively), delphinidin-3-glucoside (60 and 6 mg L -1 , respectively), petunidin-3-glucoside (85 and 8.5 mg L -1 , respectively), peonidin-3-glucoside (traces) and cyanidin-3-glucoside (traces). With high and low concentrations reflecting different levels of intake, anthocyanins showed proliferative effects on beneficial bacterial population and inhibitory effects on pathogenic species. Incubation of malvidin-3-glucoside with human faecal slurry at 0 (control), 5, 10 and 24 h showed a significant (P < 0.05) increase in total bacteria at 24 h. Significant proliferative effects were also observed in the bacteria species with beneficial effects such as Bifidobacterium spp. and Lactobacillus spp., which are known for their wide use in probiotics and for the treatment of ulcerative colitis, irritable bowel syndrome (IBS) and constipation (24) . A reduction, although not statistically significant, was observed in the potentially harmful Clostridium histolyticum following a 24-h incubation. For enocianin, a statistically significant increase (P < 0.05) was observed in Lactobacillus spp. and Bifidobacterium spp. following all incubation durations. Bacterial levels were significantly higher than those observed with malvidin-3-glucoside; however, no significant change was observed in the Clostridium coccoides-Eubacterium rectale group, comprising bacteria known for the critical roles that they play in immune homeostasis (25) , or the pathogenic C. histolycum group (26) . Similar effects have also been observed with purple sweet potato anthocyanin extracts (cyanidins and pelargonidin-based anthocyanins) using faecal samples. Following fermentation at 0, 6, 12 and 24 h, a significant increase (P < 0.05) was observed for the total bacterial count. In comparison with the control medium, a steady increase was observed in the numbers of the Bifidobacterium spp. following incubation with purple sweet potato anthocyanins, although a significant increase was observed in the bacterial population of LactobacillusEnterococcus spp. By contrast, the control media had a steady increase in the Bacteroides-Prevotella and C. histolycum during fermentation, whereas, in the media containing anthocyanins, levels were significantly reduced (P < 0.05) (27) . With respect to the release, metabolism and effect on gut microbial growth of cyclodextrin-encapsulated anthocyanins (cyanidin-3-glucoside, delphinidin-3-glucoside and malvidin-3-glucoside) on faecal slurry, between 0 and 24 h, malvidin-3-glucoside showed no significant effect on the population of Bifidobacterium spp., C. coccoides-E. rectale group, Lactobacillus-Enterococcus spp., C. histolycum group, Bacteroides spp. or Clostridium cluster IX. However, a significant increase was observed for the members of the domain Bacteria (EUBmix probe). Cyanidin-3-glucoside and delphinidin-3-glucoside on the other hand showed a significant (P < 0.05) inhibition of the C. histolycum group (28) . Table 1 Scopus search strategy TITLE-ABS-KEY (anthocyan* AND 'gut microbiota') AND (LIMIT-TO (DOCTYPE, 'ar') OR LIMIT-TO (DOCTYPE, 'cp') OR LIMIT-TO (DOCTYPE, 'ip')) AND LIMIT-TO (EXACTKEYWORD, 'Human') OR LIMIT-TO (EXACTKEYWORD, 'Intestine Flora') OR LIMIT-TO (EXACTKEYWORD, 'Humans') OR LIMIT-TO (EXACTKEYWORD, 'Polyphenols') OR LIMIT-TO (EXACTKEYWORD, 'Metabolism') OR LIMIT-TO (EXACTKEYWORD, 'Polyphenol') OR LIMIT-TO (EXACTKEYWORD, 'Article') OR LIMIT-TO (EXACTKEYWORD, 'Nonhuman') OR LIMIT-TO (EXACTKEYWORD, 'Anthocyanins')) AND (LIMIT-TO (LANGUAGE, 'English')) and Lactobacillus-Enterococcus spp. This increased proliferation was higher after enocianin treatment. (27) All three in vitro studies utilised the FISH technique for enumeration of bacterial populations.
Animal studies
Using six different berries (blackberry, blackcurrant, black raspberry, blueberry, Concord grape and Maqui berry) with structurally diverse anthocyanin profiles, Overall et al. (29) supplemented the diets in a mouse model of polygenic obesity. Anthocyanins from these individual berries were normalised to 400 lg g -1 total
anthocyanins and supplemented with animal chow for each berry category. Six-week-old mice were fed a lowfat diet (LFD) or high-fat diet (HFD) for 6 weeks to initiate the development of obesity in the HFD animals. Thereafter, the HFD animal group were randomised to different berry supplemented diets for a further 12 weeks. Faecal samples were collected from the cages, weighed and pooled at different time points (weeks 4, 8, 9 and 12) and analysed at the end of the study. Using real-time qPCR, analysis of the bacterial phyla relative abundance in the faecal samples showed that berry supplementation with blackberry and black raspberry did not change the gut microbial population shift observed with either LFD or HFD. Supplementation with Concord grape showed a significant increase in the Actinobacterial populations from 2% to 8% compared to HFD controls, which were similar in available energy (kcal g -1 ) but without anthocyanin supplementation. Blueberry and blackcurrant supplementation also showed a significant increase in the populations of obligate anaerobes Bacteroidetes from 7% to 10-12% and Actinobacteria from 2% to 9-15%, which are some of the bacteria species that are beneficial to humans. Translating the anthocyanin consumption in these animal studies to the human context, it was suggested to be equivalent to consuming 2.4 mg kg -1 day -1 or 145 mg day -1 of total anthocyanins for an average adult (30) , which could be achieved by the daily consumption of one or two servings of fresh anthocyanin-rich berries (31) . Similarly, Lacombe et al. (32) examined the effect of dietary supplementation of lowbush wild blueberries (LWB) on the colonic microbial population of SpragueDawley rats. Following control diets or LWB-supplemented diets for 6 weeks, analysis of the colon contents of the rats using shotgun sequencing showed a significant reduction in the relative abundance of the genera Lactobacillus and Enterococcus associated with the berry intervention. There was also a significant (P < 0.05) two-fold increase in the relative abundance of Bifidobacteriaceae and Coriobacteriaceae and the phylum to which they belong, Actinobacteria, in the LWB-supplemented group.
Human clinical trials
A randomised cross-over clinical trial tested the association between changes in faecal microbiota following wine interventions. Nine male participants were randomised to receive daily 275 mL of alcoholised red wine or dealcoholised red wine or 100 mL of gin for 20 days. The usual baseline dietary habits and pattern and lifestyle of participants were maintained, and additional alcoholic beverages were avoided for the duration of the study. At baseline, and following each intervention period, faecal samples were collected from participants. No significant differences in daily energy and dietary intake were observed between baseline and after each intervention. Quantification of the microbial content of faecal samples was performed using real-time qPCR. The results showed that, in comparison to gin, both red wine and dealcoholised red wine significantly (P = 0.001) increased the faecal concentration of Bifidobacterium, Enterococcus and Eggerthella lenta. Although the anthocyanin content of the red wine intervention used was not measured beforehand, the results showed that the lowest to the highest changes in Bifidobacteria tertiles were associated with a higher excretion of four phenolic metabolites related to anthocyanin metabolism in participants (23) .
Discussion
The findings from the present systematic review support the hypothesis that the consumption of foods high in anthocyanins promotes the proliferation of healthy anaerobic bacterial populations, at the same time as inhibiting the pathogenic species. Specifically, the presence of anthocyanins significantly increased the microbial population of Bifidobacterium spp. and Lactobacillus-Enterococcus spp. This observation was consistent in the in vitro, animal and human studies (23, 26, 27, 32) . These Gram-positive bacteria species have been shown to exert beneficial effects in the treatment of diarrhoea and other specific diseases, including inflammatory bowel disease, necrotising enterocolitis and colorectal cancer (33) . A number of factors, including diet, age and antibiotics, are important determinants of the gut microbiota profile, and the influence of these factors continues to change over the the lifetime (34) . The most significant of these factors is diet. In relation to anthocyanin consumption, a diet rich in fruit and vegetables has been shown to significantly alter the gut microbiota. Even though studies have observed the absence of a significant increase in total microbial population when samples were incubated with anthocyanins, Zhang et al. (27) suggested that the absence of this effect could be a result of the purple sweet potato anthocyanins including anthocyanin monomers unable to affect the total bacterial population and also that these purple sweet potato anthocyanins enhance inhibition and proliferation of different species at similar rates. In addition, Flores et al. (28) attributed this to the amount of anthocyanin used in their intervention study (20 mg L -1 ), which could have been too low to exert any significant changes. By contrast to these observations, with higher concentration (200 mg L -1 ) of anthocyanins, Hidalgo et al. (26) observed a significant (P < 0.05) proliferative and inhibitive effect in microbiota population, which was more evident in samples that were supplemented with a mixture of anthocyanins, showing the synergistic effect of anthocyanin subclasses. Another possibility is that the observed simultaneous proliferative effect on the beneficial bacteria and inhibitory effect on harmful bacteria by anthocyanins could explain the absence of any significant change in the total bacterial population because there is a natural balance between beneficial and harmful bacteria in the gut (35) . Even though observations in the in vitro models may not be extrapolated to in vivo systems, comparison of the composition and concentration of anthocyanins across studies with a significant effect on gut microbiota showed that lower concentrations with a variety of anthocyanins (malvidin, delphinidin, petunidin, peonidin and cyanidin glycosides) (26) had as much effect as a higher concentration with only one class of anthocyanins (cyanidin glycosides) (27) . Although anthocyanins were not the highest concentration of flavonoids or polyphenols in wine (23) , it is important to note that anthocyanins, and not other polyphenols, were associated with the increased level of Bifidobacteria in faecal samples. This was a result of the observed increase in microbial metabolites in urine presumably derived from anthocyanins. The anthocyanin content of all interventions used in the included studies was determined using high-performance liquid chromatography (HPLC) coupled to different detectors. HPLC has been identified as the most reliable method of measuring total anthocyanin content and individual anthocyanins in foods and biological matrices in comparison with the colorimetric method that measures only total anthocyanins (36) . With these observed beneficial effects, the exact mechanism of action of anthocyanins in the gut remains unclear, Overall et al. (29) observed an increased oxygen tension in all gut compartments associated with high-fat diets, which was attenuated by supplementing the diet with berries and berry anthocyanins. As a result, they suggested that anthocyanins may reduce oxygen tension in the gut lumen and therefore promote the proliferation of an oxygen-sensitive bacterial population. However, in the small intestine, there exists high level of oxygen, which limits bacterial growth, such that only fast growing, facultative anaerobes with the ability to bind to epithelial/ mucus are assumed to survive (37) . This highlights the difference in microbiota composition along the lower gastrointestinal tract and represents an important consideration in sampling.
On the issue of sampling, all of the studies except one that were included in this review utilised faecal samples for the quantification of anthocyanin effects on gut microbiota. In place of faecal samples, a rectal mucosal biopsy has been proposed as a better alternative in gut microbiota research in terms of assessment but not participant burden (38) . Durb an et al. (39) performed a comparative study on the bacterial community composition between faecal samples and rectal mucosal biopsies. Samples were collected from an unprepped healthy population. Comparison of the two samples showed a significant difference in the bacterial diversity between faecal and rectal mucosal samples from the same participant. Another study compared healthy subjects with IBS subjects, observing that there was a reduction in bacterial abundance and diversity in mucosal samples compared to stool samples from the same participants (40) . There is a possibility that significant differences exist in the microbial community across the six major subdivisions of the human colon (caecum, ascending colon, transverse colon, descending colon, sigmoid colon and rectum). However, the degree to which composition and functions differ remains unclear. Studying the microbial diversity of the human colon, Eckburg et al. (10) observed significant interindividual variability and differences between faecal and mucosa community composition. This discrepancy highlights the importance of sampling sites and raises the suggestion that rectal mucosal biopsy samples are more appropriate than faecal samples and should be used instead or together with faecal samples (17) . Regardless, faecal samples are still the preferred over rectal mucosa biopsy as a result of their ease of collection and being less invasive.
Other important considerations in gut microbiota research are the methods of determination and quantification. Although bacterial culture, which was previously the gold standard, is inexpensive, it produces a limited representation of the gut microbiota diversity and results in an undervaluation of real changes. Culture-independent techniques have become popular and are now the most commonly used techniques (41) . Most of the different culture-independent techniques are based on the analysis of the 16S rRNA gene. The 16S rRNA genes are highly protected across bacterial species. They also have distinctive characteristics that allow for the identification of different species (17) . The studies included in the present review employed different techniques, including FISH, qPCR and shotgun sequencing, in the determination and quantification of the gut microbiota. These techniques have different pros and cons. A qPCR, for example, although fast, is unable to identify unknown species and has an amplification bias in that the primer set used in multitemplate PCR is required to have a shared sequence across the targets. As often is the case, this shared sequence is absent in the targets. When a primer has one incongruity with some targets, the amplification efficiency is significantly reduced and, as a result, a large bias in the amplification will occur (42) . Even though the FISH technique has no PCR bias, it is dependent on probe sequences, which mean that it is also unable to identify unknown species. The shotgun sequencing on the other hand, although more adequate than the aforementioned techniques, is expensive, and the analysis of data involves complex software (17) . The major limitation of the PCR and FISH methods in comparison with the shotgun sequencing is their inability to identify unknown species. This limitation does not appear to have affected the study results because changes in bacteria species were measured with already known species, hence addressing this limitation. The availability of various methods requires a decision regarding the suitability of a given methodology in gut microbiota research. This decision will be dependent on the depth of analysis. So far, the shotgun sequencing techniques produce the most potent data, including projections of microbiota function (17) . A comparative study of 16S amplicon and shotgun sequencing on water samples found that less than 50% of phyla identified via 16S amplicon sequencing were recovered from shotgun sequencing, at the same time as also identifying approximately 27% more families (43) . A notable strength of this systematic review is the sideby-side comparison of different methods of microbiota determination, as well as effects of anthocyanins. To our knowledge, at the time of writing this article, the present systematic review appears to be the first to determine the effect of anthocyanins on gut microbiota, as well as to compare different methods of microbiota determination. Another possible strength is the specific focus on anthocyanins and their effect on gut microbiota. The synergistic effect of compounds in food (nutrients) presents some difficulty with respect to clearly defining a causal association in epidemiological research. Although nutrients are not consumed in isolation, determining the specific effects of particular nutrients is an important aspect of nutrition research.
As an emerging area of research in the last decade, very few in vitro and animal studies and even fewer clinical trials have been carried out. Consequently, there are limitations in the comparison of results and generalisation of conclusions partly as a result of the diverse sources of anthocyanins and methods of gut microbiota determination and quantification, as well as the possibility of synergistic effects of anthocyanins and/with other phytochemicals and nutrients present in the food sources resulting in the observed benefits. Another notable limitation of this review is the different control diets/samples used, which restricts generalisation of the results. However, being a limitation, it is important to note that these controlled samples/diets all had the absence of anthocyanins in common, demonstrating the modulatory effects of these natural plant pigments.
It is imperative to advance the understanding of the direct or indirect beneficial effects of anthocyanins on bacterial growth through research. It would also be noteworthy to measure these observed effects concurrently and identify further anthocyanin metabolites, as well as other health effects (e.g. vascular function and cognition), to further understand complex in vivo processes such as the gut-brain axis relationship.
Conclusions
In conclusion, research on the gut (microbiota) as a metabolic organ is still emerging and characterisation of the bacteria species present in the gut is ongoing. The results from the present review show beneficial effects, such as a significant proliferative effect on Bifidobacterium spp., known for their wide use in probiotics and for the treatment of IBS, as well as inhibition of C. histolyticum, which are pathogenic in humans. Research on the possible effect of anthocyanins on gut microbiota population is still in its early stages, and conclusions and generalisations cannot be made because of the limited evidence base and varied techniques employed in the studies, as well as because of differences in anthocyanin sources, composition, digestive stability, metabolism, and biotransformation of anthocyanins in either a food matrix or isolated supplement. This also makes it difficult to understand or determine the exact mechanism by which anthocyanins may exert these effects. Therefore, the complete effect and exact mode action of anthocyanins on gut microbiota population need much clarification, and this might be achieved partly by conducting more welldesigned human clinical trials, reaching a consensus on anthocyanin dose and form, as well as by a uniform approach to control diets. Determination of key techniques to measure (44) and confirm these findings is also vital in this field.
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